Pharmacogenetic response to albuterol among asthmatics

被引：17

作者：

Corvol, Harriet ^{[1
]}

Burchard, Esteban Gonzalez ^{[1
,2
,3
]}

机构：

[1] Univ Calif San Francisco, UCSF Lung Biol Ctr, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

来源：

PHARMACOGENOMICS | 2008年 / 9卷 / 05期

关键词：

D O I：

10.2217/14622416.9.5.505

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

Pharmacogenetics offers to individualize asthma treatment by identifying genetic variants associated with drug efficacy or adverse events. Several studies have focused on pharmacogenetic associations with albuterol, the most commonly prescribed medication for asthma worldwide. However, pharmacogenetic associations have varied within and between studies and across populations. Herein, we focus on pharmacogenetic associations between genetic variants in the beta(2)-adrenergic receptor gene and bronchodilator response to albuterol among subjects with asthma.

引用

页码：505 / 510

页数：6

共 31 条

[1]

Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma [J].

Bleecker, Eugene R. ;

Yancey, Steven W. ;

Baitinger, Leslie A. ;

Edwards, Lisa D. ;

Klotsman, Michael ;

Anderson, Wayne H. ;

Dorinsky, Paul M. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (04) :809-816

[2]

Association between bronchodilating response to short-acting β-agonist and non-synonymous single-nucleotide polymorphisms of β2-adrenoceptor gene [J].

Cho, SH ;

Oh, SY ;

Bahn, JW ;

Choi, JY ;

Chang, YS ;

Kim, YK ;

Min, KU ;

Kim, YY .

CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09) :1162-1167

[3]

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma [J].

Choudhry, S ;

Ung, N ;

Avila, PC ;

Ziv, E ;

Nazario, S ;

Casal, J ;

Torres, A ;

Gorman, JD ;

Salari, K ;

Rodriguez-Santana, JR ;

Toscano, M ;

Sylvia, JS ;

Alioto, M ;

Castro, RA ;

Salazar, M ;

Gomez, I ;

Fagan, JK ;

Salas, J ;

Clark, S ;

Lilly, C ;

Matallana, H ;

Selman, M ;

Chapela, R ;

Sheppard, D ;

Weiss, ST ;

Ford, JG ;

Boushey, HA ;

Drazen, JM ;

Rodriguez-Cintron, W ;

Silverman, EK ;

Burchard, EG .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (06) :563-570

[4]

Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [J].

Drysdale, CM ;

McGraw, DW ;

Stack, CB ;

Stephens, JC ;

Judson, RS ;

Nandabalan, K ;

Arnold, K ;

Ruano, G ;

Liggett, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10483-10488

[5]

ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality: Results from the Atherosclerosis Risk in Communities Study [J].

Ferdinands, Jill M. ;

Mannino, David M. ;

Gwinn, Marta L. ;

Bray, Molly S. .

PLOS ONE, 2007, 2 (03)

[6]

FERDINANDS JM, 2007, ATHEROSCLEROSIS, V289, P1131

[7]

The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs [J].

Green, SA ;

Rathz, DA ;

Schuster, AJ ;

Liggett, SB .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 421 (03) :141-147

[8]

GREEN SA, 1993, J BIOL CHEM, V268, P23116

[9]

INFLUENCE OF BETA(2)-ADRENERGIC RECEPTOR GENOTYPES ON SIGNAL-TRANSDUCTION IN HUMAN AIRWAY SMOOTH-MUSCLE CELLS [J].

GREEN, SA ;

TURKI, J ;

BEJARANO, P ;

HALL, IP ;

LIGGETT, SB .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (01) :25-33

[10]

Pharmacogenetics of asthma [J].

Hall, Ian P. .

CHEST, 2006, 130 (06) :1873-1878

← 1 2 3 4 →